greeksoup/ stock research
Stock research / United States / BNTX / Year to 31 December 2020

BioNTech SE (BNTX) annual results, year to 31 December 2020: revenue EUR 482 million, from the 20-F

BioNTech SE files a 20-F with the SEC once a year, in euros. In the year to 31 December 2020 it reported revenue of EUR 482 million ($550 million at the year's average rate), up 344.1% on the year before. Its profit attributable to shareholders was EUR 15.2 million, and diluted earnings per share EUR 0.06.

Revenue
EUR 482 million
+344.1% on the year
FY2017FY2020
Operating margin
-17.1%
-167.1% a year earlier
FY2017FY2020
Net income
EUR 15.2 million
FY2017FY2020
Diluted EPS
EUR 0.06
FY2017FY2020

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2019 †Dec 2020 †
Revenue109482
Cost of sales17.459.3
Gross profit91.2n/a
Research and development226645
Operating profit-182-82.4
Finance costs2.065.0
Profit before tax-179-146
Income tax-0.2-161
Profit for the year-17915.2
Profit attributable to shareholders-17915.2
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2019 †Dec 2020 †
Diluted EPS-0.850.06
Basic EPS-0.850.06
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2019 †Dec 2020 †
Cash from operations-198-13.5
Purchase of property, plant and equipment38.666.0
Free cash flow-237-79.5
Cash from investing-77.2-145
Cash from financing383895
Depreciation and amortisation33.938.7
Dividends paidn/a0.0
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2019 †Dec 2020 †
Funded by
Equity attributable to shareholders4931,372
Borrowings, as filed74.2240
Lease liabilities57.684.2
Other liabilities172622
Total equity and liabilities7982,319
Owned
Property, plant and equipment93.0227
Goodwill3.053.7
Cash and cash equivalents5191,210
Trade and other receivablesn/a166
Inventories11.764.1
Other assets171598
Total assets7982,319
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2019 †Dec 2020 †
Gross margin84.0%n/a
Operating margin-167.1%-17.1%
Net margin-164.9%3.2%
Free cash flow margin-218.3%-16.5%
Return on year-end equity-36.3%1.1%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2020, filed 27 March 2023: the filing. The figures are in euros as filed.